本公司合作信息
熱門資訊推薦
- ·關(guān)于發(fā)布廣東易短缺和急搶救藥聯(lián)盟集采項(xiàng)目采購(gòu)周期內(nèi)新一采購(gòu)年度協(xié)議采購(gòu)量的通知
- ·自治區(qū)醫(yī)療保障局關(guān)于開展醫(yī)療服務(wù)價(jià)格規(guī)范治理（第六批）暨停用部分價(jià)格項(xiàng)目的通知
- ·恒瑞醫(yī)藥：與Braveheart Bio簽署HRS-1893項(xiàng)目授權(quán)許可協(xié)議
- ·強(qiáng)強(qiáng)聯(lián)手提振醫(yī)藥板塊，阿里健康與信達(dá)生物達(dá)成戰(zhàn)略合作
- ·睿智醫(yī)藥與科恩泰達(dá)成深度戰(zhàn)略合作
- ·3億元海洋生物醫(yī)藥產(chǎn)業(yè)項(xiàng)目落戶南通
- ·聚焦打造具有全球競(jìng)爭(zhēng)力的生物醫(yī)藥產(chǎn)業(yè)，9個(gè)重大項(xiàng)目簽約
- ·復(fù)星醫(yī)藥與梯瓦達(dá)成戰(zhàn)略合作
- ·中非醫(yī)藥合作邁入新階段 21家中國(guó)藥企加入西非醫(yī)療供應(yīng)鏈平臺(tái)
- ·江蘇4項(xiàng)目入選智慧健康養(yǎng)老推廣目錄
COOPERATION
發(fā)布時(shí)間：2008/7/8 11:06:00 瀏覽次數(shù)：455 類別：其它詳情介紹
-
More effective and better foreground-The research and development of a new drug which can replace cardiac pacemaker
Currently, there is not effective drugs which can cure bradycardia, patient with severe symptoms have to use the cardiac pacemaker to sustain life. More than 600 thousand patients will be equipped with cardiac pacemakers each year. Millions of patients are expecting a new drug will can cure this disease and help them get rid of cardiac pacemakers.
To install a cardiac pacemaker not only means a large sum of money , but also the affliction and risks from the clinical operation. What's more, a lot of side effects and restrictions exist and the patient will replace with a new one in a few years. So, it is very urgent to research on some effective new drugs which are effective to patients with bradycardia.
We are physicians chief. Through 27 years in clinical search, we achieved significant therapeutic effects in curing bradycardia (mainly including sick sinus syndrome and third degree Atrio-Ventricular block) with Xindekuai.. Only after oral taking of this medicine for three days, improvement of heart rate, increase in cardiac outputs and improvement of cardiac function can be seen. These make the symptoms decrease or even disappear which enable the patients to survive without cardiac pacemakers. Widely use of the new medicine will alleviate millions of patients who suffer from the disease and also can be taken as a key project in economic exchange with foreign countries.
Xindekuai Prescription has been tested in Pharmacodynamic experiments and toxicological experiments using animal models, which have proven effectiveness.
Xindekuai Prescription has been evaluated by experts appointed by the Chamber of Scinece and Technology of Anhui Province, which has been passed.
Xindekuai Prescription win the 16th Shanghai Execllent-Invention Prize.
Xindekuai Prescription has not acquired the new drug certification up to now, we are eager to cooperate with people with wisdom and ability to develop this promising new drug. There are three advantages in developing this drug:
1. No risk : this new Prescription has been searched clinically for 27 years with excellent therapeutic effects and low adverse effests and low adverse effects. And the tests in animal models also indicate its effectiveness.
2. Low investment, short cycle: because the old drugs have been discovered, which have new use with reasonable and simple prescription.
3. well prospect: millions upon millions of patients are waiting anxi ously for the new drug to come to marker. Welcome to cooperate in developing this promising new drug.
Note: Xindekuai is a kind of compound tablet or capsule,chemical matter has been determined.
Liaison man: Doctor Lin.
聯(lián)系方式
-
聯(lián) 系 人： 林青
聯(lián)系地址： 蚌埠醫(yī)學(xué)院二附院
電 話： 0571-85885083
